Dr. Reddy's director files initial ownership

DR REDDYS LABORATORIES LTD director Shikha Sanjaya Sharma has filed an initial Form 3 reporting beneficial ownership.

Accepted by SEC EDGAR 03/27/2026 - 08:40 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Shikha Sanjaya Sharma has filed an initial Form 3 reporting beneficial ownership. The filing lists her status as a director of the company and shows no reported transactions, share purchases or sales, and no derivative positions at this time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Shikha Sanjaya Sharma's Form 3 for RDY report?

The Form 3 reports that Shikha Sanjaya Sharma is a director of DR REDDYS LABORATORIES LTD. It shows no stock purchases, sales, or derivative positions, reflecting only her status as an insider without reporting any transactions.

Does the RDY Form 3 show any insider buying or selling?

No, the Form 3 for DR REDDYS LABORATORIES LTD shows no insider buying or selling. All buy, sell, acquire, dispose, and exercise share counts are zero, indicating no reportable transactions at the time of this initial filing.

Are any derivative securities reported in the RDY Form 3?

No derivative securities are reported for DR REDDYS LABORATORIES LTD in this Form 3. The derivative summary is empty and the exercise-related counts are zero, meaning no options, warrants, or similar instruments are disclosed in this filing.

What role does the reporting person hold at DR REDDYS LABORATORIES LTD?

The reporting person, Shikha Sanjaya Sharma, is identified as a director of DR REDDYS LABORATORIES LTD. She is not listed as an officer or ten percent owner in this Form 3, only as a member of the board of directors.

Does the RDY Form 3 indicate any restructuring or gifts of shares?

No, the Form 3 shows no restructuring or gifted shares for DR REDDYS LABORATORIES LTD. Gift counts, restructuring counts, and related share figures are all zero, indicating no such movements are reported in this initial ownership statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SHARMA SHIKHA SANJAYA

(Last) (First) (Middle)

4402, SOUTH TOWER, THE IMPERIAL,

B. B. NAKASHE MARG, TARDEO,

(Street)

MUMBAI MAHARASHTRA

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ SHIKHA SANJAYA SHARMA	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)